John P. Schmid, Director at Xeris Biopharma Holdings, Inc. (XERS), bought 5,400 shares at $1.91 ($10K) on 2024-05-10, disclosed to the SEC on 2024-05-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| XERS | BUY | 2024-08-13 | $10K | — | Filing → |
| XERS | BUY | 2024-08-12 | $10K | — | Filing → |
| DSGN | BUY | 2024-03-25 | $166K | — | Filing → |